New England Securities’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q4 | $26K | Sell |
766
-157
| -17% | -$5.33K | 0.01% | 790 |
|
|
2014
Q3 | $36K | Sell |
923
-479
| -34% | -$18.7K | 0.01% | 718 |
|
|
2014
Q2 | $55K | Buy |
1,402
+212
| +18% | +$8.32K | 0.02% | 593 |
|
|
2014
Q1 | $41K | Buy |
1,190
+357
| +43% | +$12.3K | 0.02% | 617 |
|
|
2013
Q4 | $17K | Buy |
833
+540
| +184% | +$11K | 0.01% | 879 |
|
|
2013
Q3 | $7K | Buy |
293
+69
| +31% | +$1.65K | ﹤0.01% | 1087 |
|
|
2013
Q2 | $6K | Buy |
+224
| New | +$6K | ﹤0.01% | 1006 |
|